Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia - preliminary report.

Helbig, Grzegorz; Wozniczka, Krzysztof; Wieclawek, Agnieszka; Soja, Anna; Bartkowska-Chrobok, Aleksandra; Kyrcz-Krzemien, Slawomira

Helbig, Grzegorz; Wozniczka, Krzysztof; Wieclawek, Agnieszka; Soja, Anna; Bartkowska-Chrobok, Aleksandra; Kyrcz-Krzemien, Slawomira.

Afiliação

Helbig G; Department of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.
Wozniczka K; Department of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.
Wieclawek A; Department of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.
Soja A; Department of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.
Bartkowska-Chrobok A; Department of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.
Kyrcz-Krzemien S; Department of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.

Contemp Oncol (Pozn) ; 18(4): 241-5, 2014.

Article em En | MEDLINE | ID: mdl-25258581

Palavras-chave

CEBPA; FLT3-ITD; NPM1; acute myeloid leukaemia; complete remission; overall survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google